Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 3 EP applications Anna Harrison has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14166504

Methods for administering anti-IL-5 antibodies

IPC classification:
A61K 38/10
Applicant:
GlaxoSmithKline LLC
Agent:
Anna Harrison, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13727643

POLYPEPTIDE LOADED POCA NANOPARTICLES FOR ORAL ADMINISTRATION

IPC classification:
A61K 9/51, A61K 38/22, A61K 38/26
Applicant:
Glaxo Group Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP17159323

PRODUCTION METHOD

IPC classification:
C07K 16/00, C07K 16/18, C12N 7/02, C12N 15/67, C12N 15/85, C12P 21/02
Applicant:
Glaxo Group Limited
Agent:
Anna Harrison, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature